Optimal timing for initial and redistribution technetium 99m-N-NOET image acquisition

Journal of Nuclear Cardiology

Volumn 7, Issue 2, 2000, Pages 123-131

  Petruzella, Frank D ^a   Ruiz, Mirta ^a   Katsiyiannis, Peter ^a   Watson, Denny D ^a   Pasqualini, Roberto ^b   Beller, George A ^a   Glover, David K ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b CIS Bio International   (France)

Author keywords

Radionuclide imaging; Tc 99m N NOET; Vasodilator stress

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR AGONIST; BINODENOSON; BIS(N ETHOXY,N ETHYL DITHIOCARBAMATO)NITRIDO TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOG; DOSE TIME EFFECT RELATION; DRUG DISTRIBUTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; IMAGE QUALITY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LUNG; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

EID: 0034098509     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(00)90032-1     Document Type: Article

References (26)

1. Pasqualini R, Duatti A, Bellande E, Comazzi V, Brucato V, Hoffschir D, et al. Bis(dithiocarbamato) nitrido technetium-99m radiopharmaceuticals: a class of neutral myocardial imaging agents. J Nucl Med 1994;35:334-41.
2. 2)] (noet = N-Ethyl-N-ethoxydithiocarbamato). J Chem Soc Chem Commun 1992;18: 1354-5.
3. 201TI [Abstract]. J Am Coll Cardiol 1997;29(Suppl):342A.
4. Ghezzi C, Fagret D, Arvieux CC, Pathieu JP, Bontron R, Pasqualini R, et al. Myocardial kinetics of TcN-NOET: a neutral lipophilic complex tracer of regional myocardial blood flow. J Nucl Med 1995;36:1069-77.
5. Uccelli L, Giganti M, Duatti A, Bolzati C, Pasqualini R, Cittanti C, et al. Subcellular distribution of technetium-99m-N-NOET in rat myocardium. J Nucl Med 1995;36:2075-9.
6. Fagret D, Marie PY, Brunotte F, Gignati M, Le Guludec D, Bertrand A, et al. Myocardial perfusion imaging with technetium-99m-Tc NOET: comparison with thallium-201 and coronary angiography. J Nucl Med 1995;36:936-43.
7. Giganti M, Cittanti C, Colamussi P, Duatti A, Uccelli L, Chossat D, et al. Biodistribution in man of bis [(N-ethyl, N-ethoxy) dithiocarbamate] nitrido technetium (V), a promising new tracer for myocardial perfusion imaging [Abstract]. J Nucl Med 1994;35:155P.
8. Glover DK, Ruiz M, Yang JY, Koplan BA, Allen TR, Smith WH, et al. Pharmacological stress thallium scintigraphy with 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470): a novel, short-acting adenosine A sub 2A receptor agonist. Circulation 1996;94:1726-32.
9. Smith WH, Watson DD. Technical aspects of myocardial planar imaging with technetium-99m sestamibi. Am J Cardiol 1990;66:16E-22E.
10. Sinusas AJ, Beller GA, Smith WH, Vinson EL, Brookeman V, Watson DD. Quantitative planar imaging with technetium-99m methoxyisobutyl isonitrile: comparison of uptake patterns with thallium-201. J Nucl Med 1989;30:1456-63.
11. 99mTc-labeled (bis (N-ethoxy, N-ethyl dithiocarbamato) nitrido technetium (V)) can detect resting ischemia. J Nucl Cardiol 1997;4:217-25.
12. 201TI and myocardial blood flow. Circulation 1997;97:2325-31.
13. Johnson G, Nguyen K, Pasqualini R, Okada R. Interaction of technetium-99m-N-NOET with blood elements: potential mechanism of myocardial redistribution. J Nucl Med 1997;38:138-43.
14. Treher EN, Gougoutas J, Malley M, Nunn AD, Unger SE. New technetium radiopharmaceuticals: boronic acid adducts of vicinal dioxime complexes. J Label Comp Radiopharm 1986;23:118-20.
15. Narra RK, Nunn AD, Kuczynski BL, Feld T, Wedeking P, Eckelman WC. A neutral technetium-99m complex for myocardial imaging. J Nucl Med 1989;30:1830-7.
16. Leppo JA, Meerdink DJ. Comparative myocardial extraction of two technetium-labeled BATO derivatives (SQ30217, SQ30214) and thallium. J Nucl Med 1990;31:67-74.
17. Rumsey WL, Rosenspire KC, Nunn AD. Myocardial extraction of teboroxime: effects of teboroxime interaction with blood. J Nucl Med 1992;33:94-101.
18. Kronauge JF, Chiu ML, Cone JS, Davison A, Holman BL, Jones AG, et al. Comparison of neutral and cationic myocardial perfusion agents: characteristics of accumulation in cultured cells. Nucl Med Biol 1992;19:141-8.
19. Maublant JC, Moins N, Gachon P, Renoux M, Zhang Z, Veyre A. Uptake of technetium-99m-teboroxime in cultured myocardial cells: comparison with thallium-201 and technetium-99m-sestamibi. J Nucl Med 1993;34:255-9.
20. Stewart RE, Schwaiger M, Hutchins GD, Chiao PC, Gallagher KP, Nguyen N, et al. Myocardial clearance kinetics of technetium-99m-SQ30217: a marker of regional myocardial blood flow. J Nucl Med 1990;31:1183-90.
21. Stewart RE, Heyl B, O'Rourke RA, Blumgardt R, Miller DD. Demonstration of differential post-stenotic myocardial technetium-99m-teboroxime clearance kinetics after experimental ischemia and hyperemic stress. J Nucl Med 1991;32:2000-8.
22. Seldin DW, Johnson LL, Blood DK, Muschel MJ, Smith KF, Wall RM, et al. Myocardial perfusion imaging with technetium-99m SQ30217: comparison with thallium-201 and coronary anatomy. J Nucl Med 1989;30:312-9.
23. Hendel RC, McSherry B, Karimeddini M, Leppo JA. Diagnostic value of a new myocardial perfusion agent, teboroxime (SQ30217), utilizing a rapid planar imaging protocol: preliminary results. J Am Coll Cardiol 1990;16:855-61.
24. Iskandrian AS, Heo J, Nguyen T, Beer S, Cave V, Cassel D, et al. Tomographic myocardial perfusion imaging with technetium-99m teboroxime during adenosine-induced coronary hyperemia: correlation with thallium-201 imaging. J Am Coll Cardiol 1992;19: 307-12.
25. Links JM, Frank TL, Becker LC. Effect of differential tracer washout during SPECT acquisition. J Nucl Med 1991;32:2253-7.
26. O'Connor MK, Cho DS. Rapid radiotracer washout from the heart: effect on image quality in SPECT performed with a single-headed gamma camera system. J Nucl Med 1992;33:1146-51.